---
category: news
title: "Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design"
excerpt: "Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company changing lives with innovative peptide-based medicines to co-develop generative and predictive AI technologies for peptide drug design."
publishedDateTime: 2022-06-21T07:03:00Z
originalUrl: "https://www.galvnews.com/news_ap/business/article_69e4dd9c-1bf2-5c73-b853-b8b34ad7d0ba.html"
webUrl: "https://www.galvnews.com/news_ap/business/article_69e4dd9c-1bf2-5c73-b853-b8b34ad7d0ba.html"
type: article

provider:
  name: Daily News
  domain: galvnews.com

topics:
  - AI

images:
  - url: "https://bloximages.newyork1.vip.townnews.com/galvnews.com/content/tncms/custom/image/15a12480-fb7b-11ea-b7c4-87bc3f36b896.png?resize=600%2C338"
    width: 600
    height: 338
    isCached: true

secured: "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;Dqw7873MlV8c29J1b1Jmvg=="
---

